| 國立臺灣大學 |
2005 |
Immunofluorescence assay for detection of the nucleocapsid antigen of the severe acute respiratory syndrome (SARS)-associated coronavirus in cells derived from throat wash samples of patients with SARS
|
劉薏蓉; 陳培哲; 葉秀慧; 蔣瑜萍; 黃立民; 張明富; 陳世英; 楊泮池; 張上淳; 王維恭 |
| 臺大學術典藏 |
2020-12-02T02:35:47Z |
Immunofluorescence assay for detection of the nucleocapsid antigen of the severe acute respiratory syndrome (SARS)-associated coronavirus in cells derived from throat wash samples of patients with SARS
|
Liu I.-J.;Chen P.-J.;Yeh S.-H.;Chiang Y.-P.;Huang L.-M.;Chang M.-F.;Chen S.-Y.;Pan-Chyr Yang;Chang S.-C.;Wang W.-K.; Liu I.-J.; Chen P.-J.; Yeh S.-H.; Chiang Y.-P.; Huang L.-M.; Chang M.-F.; Chen S.-Y.; PAN-CHYR YANG; Chang S.-C.; Wang W.-K. |
| 臺大學術典藏 |
2019-09-09T00:54:22Z |
Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models
|
Lu, Yen-Shen; Wo, Andrew M.; Kuo, Chun-Ting; Chen, Chen-Lin; Ma, Wei-Yuan; Hsu, Wei-Fan; CHING-HUNG LIN; Hung, Guan-Syuan; Li, Chih Chi; Kuo, Chun-Ting;Chen, Chen-Lin;Li, Chih Chi;Hung, Guan-Syuan;Ma, Wei-Yuan;Hsu, Wei-Fan;Ching-Hung Lin;Lu, Yen-Shen;Wo, Andrew M. |
| 臺大學術典藏 |
2020-05-25T06:51:41Z |
Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models
|
Kuo C.-T;Chen C.-L;Li C.-C;Huang G.-S;Ma W.-Y;Hsu W.-F;Lin C.-H;Yen-Shen Lu;Wo A.M.; Kuo C.-T; Chen C.-L; Li C.-C; Huang G.-S; Ma W.-Y; Hsu W.-F; Lin C.-H; YEN-SHEN LU; Wo A.M. |
| 臺大學術典藏 |
2021-08-05T02:41:31Z |
Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models
|
Kuo C.-T;Chen C.-L;Li C.-C;Huang G.-S;Ma W.-Y;Hsu W.-F;Lin C.-H;Lu Y.-S;Wo A.M.; Kuo C.-T; Chen C.-L; Li C.-C; Huang G.-S; Ma W.-Y; Hsu W.-F; Lin C.-H; Lu Y.-S; Wo A.M.; ANDREW WO |
| 國立臺灣大學 |
1989 |
Immunogeneicity and Tolerogenicity of an Intracellular Self Antigen
|
Stockinger, B.; 林榮華; Stockinger, B.; Lin, Rong-Hwa |
| 國家衛生研究院 |
2015-06-09 |
Immunogenic compositions and uses thereof
|
Chong, CS;Liu, CC;Guo, MS;Chang, JY |
| 國家衛生研究院 |
2021-05 |
Immunogenic peptide containing a b cell epitope of tumor associated antigen L6
|
Liu, SJ;Chen, HW;Roffler, S;Huang, MH;Leng, CH |
| 國家衛生研究院 |
2013-06-18 |
Immunogenic peptides of tumor associated antigen L6 and uses thereof in cancer therapy
|
Liu, SJ;Chen, HW;Chong, PCS;Leng, CH |
| 國家衛生研究院 |
2009-09-04 |
Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses
|
Shao, HY;Yu, SL;Sia, C;Chen, Y;Chitra, E;Chen, IH;Venkatesan, N;Leng, CH;Chong, P;Chow, YH |
| 臺北醫學大學 |
2013 |
Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain
|
Hwang, Jaulang;Lin, Chun-Cheng;Chiang, Hsiao-Ling;Jan, Fan-Dan;Chen, Chiao-En;Shu, Chia-Tse |
| 國立高雄師範大學 |
2006-02-06 |
Immunogenicity and anti-Burkholderia pseudomallei activity in Balb / c mice immunized with plasmid DNA encoding flagellin
|
陳亞雷;陳師慶; Y. S. Chen;Hsiao YS;H. H. Lin;Yen CM;Ssu-Ching Chen;Ya-Lei Chen |
| 義守大學 |
2006-02 |
Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellin
|
Yao-Shen Chen; Yu-Shan Hsiao; His-Hsun Lin; Chuan-Min Yen; Ssu-Ching Chen; Ya-Lei Chen |
| 臺大學術典藏 |
2018-09-10T03:52:33Z |
Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines
|
LI-MIN HUANG; Lu, C.-Y.;Kao, C.-L.;Lee, C.-Y.;Lee, P.-I.;Huang, L.-M. |
| 國立臺灣大學 |
2001 |
Immunogenicity and Fecal Poliovirus Excretion in Sequential Use of Inactivated and Oral Poliovirus Vaccines
|
呂俊毅; 李秉穎; 黃立民; LU, CHUN-YI; LEE, PING-ING; HUANG, LI-MIN |
| 國立臺灣大學 |
2001-08 |
Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines
|
Lu, CY; Kao, CL; Lee, CY; Lee, PI; Huang, LM. |
| 臺大學術典藏 |
2020-07-03T02:18:40Z |
Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines
|
Lee C.-Y.; Lee P.-I.; Huang L.-M.; Lu C.-Y.; CHUAN-LIANG KAO; Lu C.-Y.;Chuan-Liang Kao;Lee C.-Y.;Lee P.-I.;Huang L.-M. |
| 臺大學術典藏 |
2021-01-08T02:16:44Z |
Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines
|
Huang L.-M.; Lee P.-I.; Lee C.-Y.; Kao C.-L.; Chun-Yi Lu;Kao C.-L.;Lee C.-Y.;Lee P.-I.;Huang L.-M.; CHUN-YI LU |
| 臺大學術典藏 |
2021-06-24T07:19:57Z |
Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines
|
Lu C.-Y.; Kao C.-L.; Lee C.-Y.; Lee P.-I.; LI-MIN HUANG |
| 臺大學術典藏 |
2021-01-07T06:09:15Z |
Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines
|
Lu C.-Y.;Kao C.-L.;Lee C.-Y.;Ping-Ing Lee;Huang L.-M.; Lu C.-Y.; Kao C.-L.; Lee C.-Y.; PING-ING LEE; Huang L.-M. |
| 國立臺灣大學 |
2001-12 |
Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines.
|
Lu, CY; Kao, CL; Lee, CY; Lee, PI; Huang, LM |
| 中國醫藥大學 |
2007-06 |
Immunogenicity and haemagglutination of recombinant Avibacterium paragallinarum HagA
|
徐媛曼*; 謝快樂(Happy K. Shieh); 陳偉豪(Wei-Hao Chen); 詹嘉翔(Jia-Hsiang Shiang); 張伯俊(Poa-Chun Chang) |
| 國立高雄大學 |
2007-05-23 |
Immunogenicity and Potective Efficacy of DNA Vaccination against Actinobacillus pleuropneumoniae Serotype 1 in Mice
|
Chiang, Chung-Hao; Huang, Li-Pu; Yeh, Chien-Ju; Yang, Wen-Jen |
| 國立高雄大學 |
2009-07-23 |
Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model
|
Chiang, Chung-Hao; Huang, Wei-Fang; Huang, Li-Pu; Lin, Shuen-Fuh; Yang, Wen-Jen |
| 國立臺灣大學 |
2005 |
Immunogenicity and Reactogenicity of a Reduced-Antigen-Content Diphtheria -Tetanus-Acellular Pertussis Vaccine in Healthy Taiwanese Children and Adolescents
|
黃立民; 張鑾英; 呂俊毅; 黃富源; 林奏延; 李慶雲; HUANG, LI-MIN; CHANG, LUAN-YIN; LU, CHUN-YI; HUANG, FU-YUAN; LIN, TZOU-YIEN; LEE, CHIN-YUN |
